Your browser doesn't support javascript.
loading
Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial.
Tong, T M L; van der Kooij, M K; Speetjens, F M; van Erkel, A R; van der Meer, R W; Lutjeboer, J; van Persijn van Meerten, E L; Martini, C H; Zoethout, R W M; Tijl, F G J; Blank, C U; Burgmans, M C; Kapiteijn, E.
Afiliación
  • Tong TML; Department of Medical Oncology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands. T.M.L.Tong@lumc.nl.
  • van der Kooij MK; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands. T.M.L.Tong@lumc.nl.
  • Speetjens FM; Department of Medical Oncology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • van Erkel AR; Department of Medical Oncology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • van der Meer RW; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Lutjeboer J; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • van Persijn van Meerten EL; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Martini CH; Department of Radiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Zoethout RWM; Department of Anesthesiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Tijl FGJ; Department of Anesthesiology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Blank CU; Department of Extra Corporal Circulation, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Burgmans MC; Department of Medical Oncology, Leiden University Medical Center, PO Box 9600, 2300, RC, Leiden, The Netherlands.
  • Kapiteijn E; Department of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital (NKI-AVL), PO Box 90203, 1006, BE, Amsterdam, The Netherlands.
Trials ; 23(1): 137, 2022 Feb 13.
Article en En | MEDLINE | ID: mdl-35152908
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / Quimioterapia del Cáncer por Perfusión Regional / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Úvea / Quimioterapia del Cáncer por Perfusión Regional / Melanoma Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido